The application of gene amplification technology to plasma-derived products: a view from a European member state.
Silverster
G
G
Principal Pharmaceutical Officer, Medicines Control Agency, London, U.K.
D004340:Drug Contamination / Q000331:legislation & jurisprudence / Q000517:prevention & control; D005062:European Union; D006801:Humans; D021141:Nucleic Acid Amplification Techniques; D010949:Plasma / Q000821:virology*; D012449:Safety; D006113:United Kingdom; D014773:Virology / Q000331:legislation & jurisprudence / Q000379:methods*; D014777:Virus Diseases / Q000517:prevention & control / Q000635:transmission; D014780:Viruses / Q000235:genetics / Q000302:isolation & purification